GF
TARO

Gabelli Funds’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Gabelli Funds’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,800
Closed -$252K – 1114
2014
Q2 		$252K Sell
1,800
-200
-10% -$22.2K ﹤0.01% 1030
2014
Q1 		$222K Buy
+2,000
New +$218K ﹤0.01% 1028

Other funds holding TARO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Gabelli Funds's TARO Position: Q3 2014 in Review

Gabelli Funds sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2014, closing a stake of 1,800 shares — an estimated $252K sold.

Gabelli Funds first reported a position in TARO in Q1 2014 and held it in 2 quarters. The position peaked at $252K in Q2 2014. 82 funds tracked by Wall St. Rank hold TARO as of Q3 2014.

  • Gabelli Funds reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2014 after selling out during the quarter.
  • Gabelli Funds sold 1,800 Taro Pharmaceutical Industries Ltd. shares in Q3 2014, an estimated $252K.
  • Gabelli Funds first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2014 and held it in 2 quarters.
  • Gabelli Funds's Taro Pharmaceutical Industries Ltd. position peaked at $252K in Q2 2014.
  • 82 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2014.

Based on Gabelli Funds's 13F filing for Q3 2014, filed 30 Oct 2014.